arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Sabra Health Care REIT, Inc.

SBRA

$21.04 ▲ +0.13 (+0.62%) at close

16 Visible periods

33 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

Sabra Health Care REIT, Inc. shows strong fundamentals with top-quartile Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $5.1B

Dividend Yield 5.70%

Revenue Growth 10.2% ↗

Op. Margin —

ROIC None

FCF / Share None

Trailing P/E 32.9x

Price / Book 1.9x

FCF Yield —

Debt / Equity 0.90

info Valuation on last close. End-of-day price, Aug 7, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$774.63M

↑ +10.2% —

Net Income Profit after all expenses

$155.61M

↑ +22.8% —

Long-Term Debt Long-term obligations

$2.53B

↑ +4.8% —

trending_up

Bullish Indicators

Profit Margin (%)Profit Margin (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns

Financial Health ↑

Dividend History

Dividend / share · sourced from SEC filings

$1.20 Latest / share

+0.0% YoY

-2.1% 12-yr CAGR

$1.51

FY 2014

$1.60

FY 2015

$1.67

FY 2016

$1.73

FY 2017

$1.80

FY 2018

$1.80

FY 2019

$1.35

FY 2020

$1.20

FY 2021

$1.20

FY 2022

$1.20

FY 2023

$1.20

FY 2024

$1.20

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Nov 14, 2010 10-K ↗
Revenue Growth YoY (%)	10.2% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+103%)	8.6% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+72%)	3.6% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-27%)	9.7% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+94%)	-4.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-197%)	-9.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-291%)	6.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+23%)	53.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+974%)	55.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1014%)	9.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+81%)	30.2% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+503%)	36.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+623%)	30.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+513%)	22.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+350%)	—	—
EPS Growth YoY (%)	18.5% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	800.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	34.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	81.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-75.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	7.9% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	52.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-17.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	40.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	14.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	30.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	23.3% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	22.8% Good ↓ Good Declining Year-over-year change in net income	821.1% Excellent Excellent Year-over-year change in net income	N/M	31.5% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	100.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-75.3% Weak ↓ Weak Declining Year-over-year change in net income	76.2% Excellent ↑ Excellent Improving Year-over-year change in net income	125.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-11.5% Weak ↓ Weak Declining Year-over-year change in net income	69.1% Excellent ↑ Excellent Improving Year-over-year change in net income	39.3% Excellent ↓ Excellent Declining Year-over-year change in net income	72.8% Excellent Excellent Year-over-year change in net income	51.9% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Revenue CAGR 3Y (%)	7.4% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	7.3% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	2.7% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	-1.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-3.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	13.8% Good ↓ Good Declining Compound annual revenue growth over 3 years	36.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	37.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	30.3% Excellent → Excellent Stable Compound annual revenue growth over 3 years	24.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	32.3% Excellent Excellent Compound annual revenue growth over 3 years	29.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	5.3% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	1.2% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	0.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	9.0% Good ↓ Good Declining Compound annual revenue growth over 5 years	16.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	20.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	29.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	35.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	31.5% Excellent Excellent Compound annual revenue growth over 5 years	25.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	-55.3% Weak Weak Compound annual EPS growth over 3 years	—	—	-21.8% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-26.2% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	10.8% Good ↓ Good Declining Compound annual EPS growth over 3 years	21.0% Excellent → Excellent Stable Compound annual EPS growth over 3 years	10.1% Good ↓ Good Declining Compound annual EPS growth over 3 years	27.9% Excellent Excellent Compound annual EPS growth over 3 years	22.5% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Nov 14, 2010 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	20.1% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-20%)	18.0% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-28%)	2.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-92%)	-12.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-150%)	-19.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-180%)	23.1% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-8%)	10.4% Fair ↓ Fair Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-58%)	44.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+79%)	39.0% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+56%)	27.0% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+8%)	33.2% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+33%)	25.6% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	25.0% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	18.9% Good Good Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-24%)	15.2% Good Good Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-39%)	—
FCF Margin (%) (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF / Net Income (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

🎯 Is capital allocation efficient? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Nov 14, 2010 10-K ↗
Return on Invested Capital (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Common Equity (%) (%)	5.5% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-31%)	4.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-42%)	0.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-94%)	-2.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-3.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	—	2.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-75%)	8.6% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+7%)	4.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-42%)	6.9% Caution → Caution Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-14%)	7.5% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-6%)	5.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-38%)	7.3% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-8%)	6.4% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-20%)	3.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-51%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Nov 14, 2010 10-K ↗
Debt to Equity (x)	0.90x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-10%)	—	0.86x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-14%)	0.82x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-18%)	0.71x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-29%)	—	0.69x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-31%)	—	—	—	1.33x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+33%)	1.16x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+16%)	1.50x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+50%)	—	—	—
Interest Coverage (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Debt (USD)	$2.46B	$-60.47M	$2.37B	$2.46B	$2.28B	$2.31B	$2.36B	$-50.23M	$-518.63M	$-25.66M	$1.39B	$1.03B	$683.77M	$-17.10M	$-42.25M	$-67.13M
Debt / EBITDA (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Nov 14, 2010 10-K ↗
Revenue per Share (USD)	$3.21	$3.01	$2.80	$2.71	$2.60	$2.90	$3.54	$3.50	$3.84	$3.99	$3.84	$3.96	$3.59	$2.78	$2.80	—
Basic EPS, GAAP (USD)	$0.64	$0.54	$0.06	$-0.34	$-0.52	$0.67	$0.37	$1.51	$1.40	$0.92	$1.11	$0.79	$0.69	$0.53	$0.43	—
Free Cash Flow per Share (USD) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend per Share (USD)	$1.20	$1.20	$1.20	$1.20	$1.20	$1.35	$1.80	$1.80	$1.73	$1.67	$1.60	$1.51	$1.36	$1.32	$0.96	—
Book Value per Share (USD)	$11.21	$11.54	$12.12	$13.23	$14.67	—	$17.00	$18.23	$19.26	$15.56	$16.17	$15.95	$11.86	$8.23	$8.85	$7.07
Tangible Book Value per Share (USD)	$11.21	$11.54	$12.12	$13.23	$14.67	—	$17.00	$18.23	$19.26	$15.56	$16.17	$15.95	$11.86	$8.23	$8.85	$7.07
Basic Weighted Avg Shares (shares)	241.31M	233.50M	231.20M	230.95M	219.07M	206.22M	187.17M	178.31M	105.62M	65.28M	62.24M	46.35M	37.51M	37.06M	30.11M	—
Dividend Payout Ratio (%)	187.5% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	222.2% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	2000.0% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	-352.9% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	-230.8% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	201.5% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	486.5% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	119.2% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	123.6% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	181.5% Weak → Weak Stable Dividends paid as a percentage of earnings Optimal: 30-60%	144.1% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	191.1% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	197.1% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	249.1% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	223.3% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Nov 14, 2010 10-K ↗
LT Debt (USD)	$2.53B	—	$2.41B	$2.51B	$2.39B	$2.37B	$2.40B	—	—	—	$1.40B	$1.09B	$688.08M	—	—	—
Total Equity (USD)	$2.82B	$2.74B	$2.80B	$3.06B	$3.38B	—	$3.49B	$3.25B	$3.43B	$1.02B	$1.05B	$941.87M	$460.16M	$305.49M	$326.57M	$177.19M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Nov 14, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$774.63M	$703.24M	$647.51M	$624.81M	$569.54M	$598.57M	$661.74M	$623.41M	$405.65M	$260.53M	$238.86M	$183.52M	$134.78M	$103.17M	$84.22M	—
Depreciation Expense (USD)	$187.00M	$169.62M	$183.09M	$187.78M	$178.99M	$176.74M	$181.55M	$191.38M	$113.88M	$68.47M	$63.08M	$43.33M	$33.28M	$30.26M	$26.59M	—
Net Income, GAAP (USD)	$155.61M	$126.71M	$13.76M	$-77.61M	$-113.26M	$138.42M	$69.00M	$279.08M	$158.38M	$70.28M	$79.41M	$46.95M	$33.72M	$19.51M	$12.84M	—
Operating Cash Flow (USD)	$348.61M	$310.54M	$300.57M	$315.73M	$356.39M	$354.85M	$372.48M	$360.59M	$135.79M	$176.74M	$121.10M	$85.34M	$62.10M	$56.25M	$44.70M	—

🏛️ Sector-Specific 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Nov 14, 2010 10-K ↗
FFO (approx.) (USD)	$342.61M	$296.33M	$196.84M	$110.18M	$65.73M	$315.15M	$250.54M	$470.46M	$272.26M	$138.75M	$142.49M	$90.28M	$67.00M	$49.78M	$39.43M	—
FFO per Share (approx.) (USD)	$1.42	$1.27	$0.85	$0.48	$0.30	$1.53	$1.34	$2.64	$2.58	$2.13	$2.29	$1.95	$1.79	$1.34	$1.31	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 62 quarters

Sabra Health Care REIT, Inc.

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SBRA with peers